10-K Filing

ZIMMER BIOMET HOLDINGS, INC. CIK: 1136869 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001564590-21-007163`
Period End Date	20201231
Filing Date	20210222
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	zbh-10k_20201231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 98 Cash Flow Statement 102 Stockholders Equity 25 Comprehensive Income 27

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	311.40M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	309.90M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$802.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$617.90M	USD	Point-in-time
Accounts receivable, less allowance for credit losses	`AccountsReceivableNetCurrent`	$1.36B	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	103.80M	shares	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	103.90M	shares	Point-in-time
Accounts receivable, less allowance for credit losses	`AccountsReceivableNetCurrent`	$1.45B	USD	Point-in-time
Inventories	`InventoryNet`	$2.45B	USD	Point-in-time
Inventories	`InventoryNet`	$2.38B	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$377.80M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$357.10M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$5.08B	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$4.72B	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$2.05B	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$2.08B	USD	Point-in-time
Goodwill	`Goodwill`	$9.26B	USD	Point-in-time
Goodwill	`Goodwill`	$9.60B	USD	Point-in-time
Goodwill	`Goodwill`	$9.59B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$7.26B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$7.06B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$980.10M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$969.40M	USD	Point-in-time
Total Assets	`Assets`	$24.42B	USD	Point-in-time
Total Assets	`Assets`	$24.64B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$330.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$400.90M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$59.50M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$126.70M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.41B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.67B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$500.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$1.50B	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$2.56B	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$3.44B	USD	Point-in-time
Deferred income taxes, net	`DeferredIncomeTaxLiabilitiesNet`	$790.40M	USD	Point-in-time
Deferred income taxes, net	`DeferredIncomeTaxLiabilitiesNet`	$840.10M	USD	Point-in-time
Long-term income tax payable	`AccruedIncomeTaxesNoncurrent`	$685.10M	USD	Point-in-time
Long-term income tax payable	`AccruedIncomeTaxesNoncurrent`	$588.10M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$656.40M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$557.80M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$7.63B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$6.72B	USD	Point-in-time
Total Liabilities	`Liabilities`	$12.22B	USD	Point-in-time
Total Liabilities	`Liabilities`	$12.25B	USD	Point-in-time
Commitments and Contingencies (Note 21)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 21)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value, one billion shares authorized, 311.4 million (309.9 million in 2019) issued	`CommonStockValue`	$3.10M	USD	Point-in-time
Common stock, $0.01 par value, one billion shares authorized, 311.4 million (309.9 million in 2019) issued	`CommonStockValue`	$3.10M	USD	Point-in-time
Paid-in capital	`AdditionalPaidInCapitalCommonStock`	$8.92B	USD	Point-in-time
Paid-in capital	`AdditionalPaidInCapitalCommonStock`	$9.12B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$10.09B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$10.43B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-241.90M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-297.80M	USD	Point-in-time
Treasury stock, 103.8 million shares (103.9 million shares in 2019)	`TreasuryStockValue`	$6.72B	USD	Point-in-time
Treasury stock, 103.8 million shares (103.9 million shares in 2019)	`TreasuryStockValue`	$6.72B	USD	Point-in-time
Total Zimmer Biomet Holdings, Inc. stockholders' equity	`StockholdersEquity`	$12.19B	USD	Point-in-time
Total Zimmer Biomet Holdings, Inc. stockholders' equity	`StockholdersEquity`	$12.39B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$5.20M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$4.70M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.74B	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.39B	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.20B	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.28B	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$24.64B	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$24.42B	USD	Point-in-time

Income Statement 98 line items

Line Item	Tag	Value	Unit	Period
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.78B	USD	1 Quarter
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.93B	USD	1 Quarter
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.89B	USD	1 Quarter
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.09B	USD	1 Quarter
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.99B	USD	1 Quarter
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.13B	USD	1 Quarter
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$7.98B	USD	Annual
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.23B	USD	1 Quarter
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.98B	USD	1 Quarter
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$7.02B	USD	Annual
Net Sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$7.93B	USD	Annual
Cost of products sold, excluding intangible asset amortization	`CostOfGoodsAndServicesSold`	$2.27B	USD	Annual
Cost of products sold, excluding intangible asset amortization	`CostOfGoodsAndServicesSold`	$2.13B	USD	Annual
Cost of products sold, excluding intangible asset amortization	`CostOfGoodsAndServicesSold`	$2.25B	USD	Annual
Intangible asset amortization	`AmortizationOfIntangibleAssets`	$584.30M	USD	Annual
Intangible asset amortization	`AmortizationOfIntangibleAssets`	$597.60M	USD	Annual
Intangible asset amortization	`AmortizationOfIntangibleAssets`	$595.90M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$391.70M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$449.30M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$372.00M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.38B	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.34B	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.18B	USD	Annual
Goodwill and intangible asset impairment	`GoodwillAndIntangibleAssetImpairment`	$979.70M	USD	Annual
Goodwill and intangible asset impairment	`GoodwillAndIntangibleAssetImpairment`	$645.00M	USD	Annual
Goodwill and intangible asset impairment	`GoodwillAndIntangibleAssetImpairment`	$70.10M	USD	Annual
Restructuring and other cost reduction initiatives	`RestructuringAndOtherCostReductionInitiatives`	$50.00M	USD	Annual
Restructuring and other cost reduction initiatives	`RestructuringAndOtherCostReductionInitiatives`	$116.90M	USD	Annual
Restructuring and other cost reduction initiatives	`RestructuringAndOtherCostReductionInitiatives`	$34.20M	USD	Annual
Quality remediation	`QualityRemediationCosts`	$82.40M	USD	Annual
Quality remediation	`QualityRemediationCosts`	$146.90M	USD	Annual
Quality remediation	`QualityRemediationCosts`	$50.90M	USD	Annual
Acquisition, integration and related	`AcquisitionIntegrationAndRelatedExpenses`	$23.80M	USD	Annual
Acquisition, integration and related	`AcquisitionIntegrationAndRelatedExpenses`	$12.20M	USD	Annual
Acquisition, integration and related	`AcquisitionIntegrationAndRelatedExpenses`	$99.50M	USD	Annual
Operating expenses	`CostsAndExpenses`	$7.11B	USD	Annual
Operating expenses	`CostsAndExpenses`	$6.84B	USD	Annual
Operating expenses	`CostsAndExpenses`	$7.90B	USD	Annual
Operating (Loss) Profit	`OperatingIncomeLoss`	$1.14B	USD	Annual
Operating (Loss) Profit	`OperatingIncomeLoss`	$-87.80M	USD	Annual
Operating (Loss) Profit	`OperatingIncomeLoss`	$33.80M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$25.40M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-15.60M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-4.80M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNet`	$-289.30M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNet`	$-226.90M	USD	Annual
Interest expense, net	`InterestIncomeExpenseNet`	$-212.00M	USD	Annual
(Loss) Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-274.40M	USD	Annual
(Loss) Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$905.80M	USD	Annual
(Loss) Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-271.10M	USD	Annual
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$-137.00M	USD	Annual
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$-225.70M	USD	Annual
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$108.20M	USD	Annual
Net (Loss) Earnings	`ProfitLoss`	$1.13B	USD	Annual
Net (Loss) Earnings	`ProfitLoss`	$-137.40M	USD	Annual
Net (Loss) Earnings	`ProfitLoss`	$-379.30M	USD	Annual
Less: Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-100.00K	USD	Annual
Less: Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.50M	USD	Annual
Less: Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-100.00K	USD	Annual
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$-138.90M	USD	Annual
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$242.50M	USD	1 Quarter
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$-379.20M	USD	Annual
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$-206.60M	USD	1 Quarter
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$320.70M	USD	1 Quarter
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$431.10M	USD	1 Quarter
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$1.13B	USD	Annual
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$133.70M	USD	1 Quarter
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$246.10M	USD	1 Quarter
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$-508.50M	USD	1 Quarter
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc.	`NetIncomeLoss`	$333.70M	USD	1 Quarter
(Loss) Earnings Per Common Share - Basic	`EarningsPerShareBasic`	$1.17	USD	1 Quarter
(Loss) Earnings Per Common Share - Basic	`EarningsPerShareBasic`	$2.10	USD	1 Quarter
(Loss) Earnings Per Common Share - Basic	`EarningsPerShareBasic`	$1.56	USD	1 Quarter
(Loss) Earnings Per Common Share - Basic	`EarningsPerShareBasic`	$1.61	USD	1 Quarter
(Loss) Earnings Per Common Share - Basic	`EarningsPerShareBasic`	$1.20	USD	1 Quarter
(Loss) Earnings Per Common Share - Basic	`EarningsPerShareBasic`	$-0.67	USD	Annual
(Loss) Earnings Per Common Share - Basic	`EarningsPerShareBasic`	$-1.86	USD	Annual
(Loss) Earnings Per Common Share - Basic	`EarningsPerShareBasic`	$-2.46	USD	1 Quarter
(Loss) Earnings Per Common Share - Basic	`EarningsPerShareBasic`	$-1.00	USD	1 Quarter
(Loss) Earnings Per Common Share - Basic	`EarningsPerShareBasic`	$0.65	USD	1 Quarter
(Loss) Earnings Per Common Share - Basic	`EarningsPerShareBasic`	$5.52	USD	Annual
(Loss) Earnings Per Common Share - Diluted	`EarningsPerShareDiluted`	$1.59	USD	1 Quarter
(Loss) Earnings Per Common Share - Diluted	`EarningsPerShareDiluted`	$0.65	USD	1 Quarter
(Loss) Earnings Per Common Share - Diluted	`EarningsPerShareDiluted`	$2.08	USD	1 Quarter
(Loss) Earnings Per Common Share - Diluted	`EarningsPerShareDiluted`	$-2.46	USD	1 Quarter
(Loss) Earnings Per Common Share - Diluted	`EarningsPerShareDiluted`	$1.20	USD	1 Quarter
(Loss) Earnings Per Common Share - Diluted	`EarningsPerShareDiluted`	$1.54	USD	1 Quarter
(Loss) Earnings Per Common Share - Diluted	`EarningsPerShareDiluted`	$1.16	USD	1 Quarter
(Loss) Earnings Per Common Share - Diluted	`EarningsPerShareDiluted`	$5.47	USD	Annual
(Loss) Earnings Per Common Share - Diluted	`EarningsPerShareDiluted`	$-1.00	USD	1 Quarter
(Loss) Earnings Per Common Share - Diluted	`EarningsPerShareDiluted`	$-1.86	USD	Annual
(Loss) Earnings Per Common Share - Diluted	`EarningsPerShareDiluted`	$-0.67	USD	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	205.10M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	207.00M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	203.50M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	207.00M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	203.50M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	206.70M	shares	Annual

Cash Flow Statement 102 line items

Line Item	Tag	Value	Unit	Period
Net (Loss) Earnings	`ProfitLoss`	$1.13B	USD	Annual
Net (Loss) Earnings	`ProfitLoss`	$-137.40M	USD	Annual
Net (Loss) Earnings	`ProfitLoss`	$-379.30M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.01B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.03B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.04B	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$84.30M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$79.70M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$65.50M	USD	Annual
Goodwill and intangible asset impairment	`GoodwillAndIntangibleAssetImpairment`	$979.70M	USD	Annual
Goodwill and intangible asset impairment	`GoodwillAndIntangibleAssetImpairment`	$645.00M	USD	Annual
Goodwill and intangible asset impairment	`GoodwillAndIntangibleAssetImpairment`	$70.10M	USD	Annual
Deferred income tax benefit (provision)	`DeferredIncomeTaxExpenseBenefit`	$-538.70M	USD	Annual
Deferred income tax benefit (provision)	`DeferredIncomeTaxExpenseBenefit`	$12.00M	USD	Annual
Deferred income tax benefit (provision)	`DeferredIncomeTaxExpenseBenefit`	$13.40M	USD	Annual
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-150.80M	USD	Annual
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$111.40M	USD	Annual
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-291.10M	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$70.00M	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$93.80M	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$-213.60M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$199.50M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$125.20M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$40.80M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$155.90M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-42.00M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-95.10M	USD	Annual
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$17.90M	USD	Annual
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-8.40M	USD	Annual
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-69.50M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.75B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.20B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.59B	USD	Annual
Additions to instruments	`AdditionsToInstruments`	$291.70M	USD	Annual
Additions to instruments	`AdditionsToInstruments`	$276.30M	USD	Annual
Additions to instruments	`AdditionsToInstruments`	$315.90M	USD	Annual
Additions to other property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$117.50M	USD	Annual
Additions to other property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$162.70M	USD	Annual
Additions to other property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$207.10M	USD	Annual
Net investment hedge settlements	`ProceedsFromHedgeInvestingActivities`	$53.50M	USD	Annual
Net investment hedge settlements	`ProceedsFromHedgeInvestingActivities`	$69.20M	USD	Annual
Net investment hedge settlements	`ProceedsFromHedgeInvestingActivities`	$48.10M	USD	Annual
Business combination investments, net of acquired cash	`PaymentsToAcquireBusinessTwoNetOfCashAcquired`	$235.50M	USD	Annual
Business combination investments, net of acquired cash	`PaymentsToAcquireBusinessTwoNetOfCashAcquired`	$37.10M	USD	Annual
Business combination investments, net of acquired cash	`PaymentsToAcquireBusinessTwoNetOfCashAcquired`	$15.30M	USD	Annual
Investments in other assets	`PaymentsForProceedsFromOtherInvestingActivities`	$22.20M	USD	Annual
Investments in other assets	`PaymentsForProceedsFromOtherInvestingActivities`	$31.50M	USD	Annual
Investments in other assets	`PaymentsForProceedsFromOtherInvestingActivities`	$19.70M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-613.80M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-729.30M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-416.60M	USD	Annual
Proceeds from senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$749.50M	USD	Point-in-time
Proceeds from senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$1.50B	USD	Annual
Proceeds from senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$549.20M	USD	Annual
Proceeds from senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$749.50M	USD	Annual
Proceeds from senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$549.20M	USD	Point-in-time
Proceeds from multicurrency revolving facility	`ProceedsFromLinesOfCredit`	$400.00M	USD	Annual
Payments on multicurrency revolving facility	`RepaymentsOfLinesOfCredit`	$400.00M	USD	Annual
Redemption of senior notes	`MaturitiesOfSeniorDebt`	$1.75B	USD	Annual
Redemption of senior notes	`MaturitiesOfSeniorDebt`	$500.00M	USD	Annual
Redemption of senior notes	`MaturitiesOfSeniorDebt`	$1.15B	USD	Annual
Proceeds from term loans	`ProceedsFromIssuanceOfUnsecuredDebt`	$675.00M	USD	Annual
Proceeds from term loans	`ProceedsFromIssuanceOfUnsecuredDebt`	$200.00M	USD	Annual
Payments on term loans	`RepaymentsOfUnsecuredDebt`	$1.43B	USD	Annual
Payments on term loans	`RepaymentsOfUnsecuredDebt`	$960.00M	USD	Annual
Net payments on other debt	`ProceedsFromRepaymentsOfOtherDebt`	$-5.30M	USD	Annual
Net payments on other debt	`ProceedsFromRepaymentsOfOtherDebt`	$-3.90M	USD	Annual
Dividends paid to stockholders	`PaymentsOfDividendsCommonStock`	$198.50M	USD	Annual
Dividends paid to stockholders	`PaymentsOfDividendsCommonStock`	$196.70M	USD	Annual
Dividends paid to stockholders	`PaymentsOfDividendsCommonStock`	$195.20M	USD	Annual
Proceeds from employee stock compensation plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$107.90M	USD	Annual
Proceeds from employee stock compensation plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$129.80M	USD	Annual
Proceeds from employee stock compensation plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$158.20M	USD	Annual
Net cash flows from unremitted collections from factoring programs	`NetCashFlowsBetweenTransfereeAndTransferorUnremittedCollectionsFromFactoringPrograms`	$54.60M	USD	Annual
Net cash flows from unremitted collections from factoring programs	`NetCashFlowsBetweenTransfereeAndTransferorUnremittedCollectionsFromFactoringPrograms`	$12.20M	USD	Annual
Net cash flows from unremitted collections from factoring programs	`NetCashFlowsBetweenTransfereeAndTransferorUnremittedCollectionsFromFactoringPrograms`	$36.70M	USD	Annual
Business combination contingent consideration payments	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$15.00M	USD	Annual
Business combination contingent consideration payments	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$2.90M	USD	Annual
Business combination contingent consideration payments	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$19.80M	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$3.50M	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$22.30M	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$4.90M	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$900.00K	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-8.30M	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-6.70M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.30B	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-421.80M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-779.90M	USD	Annual
Effect of exchange rates on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-10.20M	USD	Annual
Effect of exchange rates on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-1.50M	USD	Annual
Effect of exchange rates on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$15.30M	USD	Annual
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$184.20M	USD	Annual
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$18.40M	USD	Annual
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$75.10M	USD	Annual
Cash and cash equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$524.40M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$802.10M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$617.90M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$542.80M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$524.40M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$802.10M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$617.90M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$542.80M	USD	Point-in-time

Stockholders Equity 25 line items

Line Item	Tag	Value	Unit	Period
Cash dividend declared per share	`CommonStockDividendsPerShareDeclared`	$0.96	USD	Annual
Cash dividend declared per share	`CommonStockDividendsPerShareDeclared`	$0.96	USD	Annual
Cash dividend declared per share	`CommonStockDividendsPerShareDeclared`	$0.96	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.74B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.39B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.20B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.28B	USD	Point-in-time
Net (loss) earnings	`ProfitLoss`	$1.13B	USD	Annual
Net (loss) earnings	`ProfitLoss`	$-137.40M	USD	Annual
Net (loss) earnings	`ProfitLoss`	$-379.30M	USD	Annual
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-55.90M	USD	Annual
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-61.30M	USD	Annual
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-54.50M	USD	Annual
Cash dividends declared	`DividendsCommonStockCash`	$197.20M	USD	Annual
Cash dividends declared	`DividendsCommonStockCash`	$198.90M	USD	Annual
Cash dividends declared	`DividendsCommonStockCash`	$195.50M	USD	Annual
Acquisition of noncontrolling interest	`MinorityInterestDecreaseFromRedemptions`	$1.00M	USD	Annual
Sale of shares in a subsidiary without loss of control	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$5.20M	USD	Annual
Stock compensation plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$202.90M	USD	Annual
Stock compensation plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$236.90M	USD	Annual
Stock compensation plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$171.50M	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.74B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.39B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.20B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.28B	USD	Point-in-time

Comprehensive Income 27 line items

Line Item	Tag	Value	Unit	Period
Net (Loss) Earnings	`ProfitLoss`	$1.13B	USD	Annual
Net (Loss) Earnings	`ProfitLoss`	$-137.40M	USD	Annual
Net (Loss) Earnings	`ProfitLoss`	$-379.30M	USD	Annual
Foreign currency cumulative translation adjustments, net of tax	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-135.40M	USD	Annual
Foreign currency cumulative translation adjustments, net of tax	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$25.60M	USD	Annual
Foreign currency cumulative translation adjustments, net of tax	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.50M	USD	Annual
Unrealized cash flow hedge (losses)/gains, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$30.60M	USD	Annual
Unrealized cash flow hedge (losses)/gains, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$68.20M	USD	Annual
Unrealized cash flow hedge (losses)/gains, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$-33.50M	USD	Annual
Reclassification adjustments on cash flow hedges, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax`	$35.10M	USD	Annual
Reclassification adjustments on cash flow hedges, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax`	$38.50M	USD	Annual
Reclassification adjustments on cash flow hedges, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax`	$-23.60M	USD	Annual
Adjustments to prior service cost and unrecognized actuarial assumptions, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$9.50M	USD	Annual
Adjustments to prior service cost and unrecognized actuarial assumptions, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$48.50M	USD	Annual
Adjustments to prior service cost and unrecognized actuarial assumptions, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$17.70M	USD	Annual
Total Other Comprehensive Loss	`OtherComprehensiveIncomeLossNetOfTax`	$-54.50M	USD	Annual
Total Other Comprehensive Loss	`OtherComprehensiveIncomeLossNetOfTax`	$-55.90M	USD	Annual
Total Other Comprehensive Loss	`OtherComprehensiveIncomeLossNetOfTax`	$-61.30M	USD	Annual
Comprehensive (Loss) Income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Annual
Comprehensive (Loss) Income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-193.30M	USD	Annual
Comprehensive (Loss) Income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-440.60M	USD	Annual
Comprehensive Income (Loss) Attributable to Noncontrolling Interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-100.00K	USD	Annual
Comprehensive Income (Loss) Attributable to Noncontrolling Interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$1.50M	USD	Annual
Comprehensive Income (Loss) Attributable to Noncontrolling Interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-100.00K	USD	Annual
Comprehensive (Loss) Income Attributable to Zimmer Biomet Holdings, Inc.	`ComprehensiveIncomeNetOfTax`	$-194.80M	USD	Annual
Comprehensive (Loss) Income Attributable to Zimmer Biomet Holdings, Inc.	`ComprehensiveIncomeNetOfTax`	$1.08B	USD	Annual
Comprehensive (Loss) Income Attributable to Zimmer Biomet Holdings, Inc.	`ComprehensiveIncomeNetOfTax`	$-440.50M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.